NIH-funded research R21 grant

SHE-bot: An AI Chatbot to support U.S.-based Chinese-origin women facing intimate partner violence

Official title: SHE-bot: Developing an AI Chatbot to Support U.S.-Based Women of Chinese Origin Experiencing Intimate Partner Violence

Funded at University of Texas at Austin · NIH-11441815 · Data updated 2026-11-12

A new AI chatbot called SHE-bot aims to help Chinese-origin women in the U.S. cope with intimate partner violence by offering culturally respectful mental health support and safety resources.

Quick facts

Grant typeR21 grant
Study typeNIH-funded research
Funding institutionUniversity of Texas at Austin
NIH-funded
Lab location1 site (Austin, United States)
Project startSeptember 18, 2026
Project endJuly 31, 2028
Funding year2026
Award (this year)$246,160
NIH project number1R21NR022352-01
Project IDNIH-11441815 on NIH RePORTER

Who could benefit from this research

Could help

Women of Chinese origin in the U.S. who experience intimate partner violence and seek mental health support.

Less likely to help

Women without IPV-related needs or those not seeking AI-based support may not benefit.

What this research studies

This project develops an AI-powered chatbot to deliver the Self-Compassion, Health, and Empowerment (SHE) program to women of Chinese origin who experience IPV. The chatbot will provide relaxation techniques, self-compassion exercises, and guidance for coping with depression, anxiety, and PTSD symptoms in a linguistically and culturally appropriate manner. It is designed for easy access, scalability, and sustainability within real-world settings, with a focus on safety and user empowerment.

Why it matters

Potential benefit: If successful, the SHE-bot could make culturally tailored IPV support more accessible and reduce mental health symptoms for participants.

How similar studies have gone: Similar digital mental health tools have shown promise, but this is a novel culturally tailored approach for a specific population.

Where this research is happening

  • University of Texas at Austin
    Austin, United States
    Active

Researchers

  • Principal investigator: Li, Yang — University of Texas at Austin
  • Study coordinator: Li, Yang

Related research

Other NIH-funded projects on the same topics.

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.